MedTrace Logo

Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection

NCT06189183 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-04-01

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficiency and toxicity of adjuvant hypofractionation radiotherapy for thymic epithelial tumours after complete resection.

Conditions

  • Thymus Neoplasms

Interventions

RADIATION

Adjuvant Hypofractionation Radiotherapy

Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection

Sponsors & Collaborators

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    lead OTHER

Principal Investigators

  • Tao Zhang, Dr. · National Cancer Center/Cancer Hospital, CAMS

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-11
Primary Completion
2030-12-31
Completion
2040-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06189183 on ClinicalTrials.gov